Skip to contentO
OptimizeRx Corp
O
OPRXOptimizeRx Corp Q1 2016 · 10-Q
Revenue$1.76M$1.76M+18.3% vs Q1 2015 Net Income-$351.92K-$351.92KN/M vs Q1 2015 EPS Diluted-$0.01-$0.01— vs Q1 2015 Gross Profit$866,735+18.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
Operating Cash Flow-$286,087N/M Free Cash Flowderived-$300,594— Margins · derivedGross margin49.3%+0.1 pt vs Q1 2015
Operating margin-20.6%−13.1 pt vs Q1 2015
Net margin-20.0%−12.5 pt vs Q1 2015
ended Mar 31, 2016 · filed May 9, 2016 · 39 d after period end